Market revenue in 2023 | USD 40.1 million |
Market revenue in 2030 | USD 90.1 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Sequencing & Data Analytics Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Kits & reagents was the largest segment with a revenue share of 61.6% in 2023. Horizon Databook has segmented the Sweden metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
In Sweden, increased usage of metagenomics in clinical practice for proper diagnosis and treatment is driving the market. For instance, in 2021, around 2,000 samples were analyzed with whole-exome sequencing and 5,000 samples with whole-genome sequencing in a clinical routine in Sweden.
In addition, the collaboration between SciLifeLab Clinical Genomics platform and Genomic Medicine Sweden (GMS) to develop precision diagnostics has enabled whole-genome sequencing for rare diseases in hospitals. Increasing adoption of sequencing techniques in hospitals and laboratories has further boosted the demand for metagenomics technologies.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account